November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Amazon: Still A Buy, But Caution Is Key
Why Apple Doesn’t Need Nvidia
Nvidia: Still Looks Inexpensive Despite Racing To The Top
Nvidia Q3: Blackwell Ramp Just Started
Nvidia: This Is Only The Beginning
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Arbutus Biopharma (ABUS) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: December 7, 2024 (14:06)
Sector: HealthcareThe share price of Arbutus Biopharma Corp. (ABUS) now
Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2025, 2026, 2027. How much will one Arbutus Biopharma share be worth in 2025 - 2027?
When should I take profit in Arbutus Biopharma stock? When should I record a loss on Arbutus Biopharma stock? What are analysts' forecasts for Arbutus Biopharma stock? What is the future of Arbutus Biopharma stock? We forecast Arbutus Biopharma stock performance using neural networks based on historical data on Arbutus Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Arbutus Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arbutus Biopharma shares. This happens once a day.
Historical and forecast chart of Arbutus Biopharma stock
The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Arbutus Biopharma stock price can be found in the table below.
Long-term forecasts by years.
Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.
Arbutus Biopharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 09 | 3.70 | 3.67 | 3.72 | 1.29 |
| Dec 10 | 3.72 | 3.70 | 3.74 | 1.06 |
| Dec 11 | 3.73 | 3.70 | 3.76 | 1.52 |
| Dec 12 | 3.73 | 3.70 | 3.73 | 0.95 |
| Dec 13 | 3.73 | 3.71 | 3.75 | 1.17 |
| Dec 14 | 3.75 | 3.73 | 3.78 | 1.27 |
| Dec 15 | 3.75 | 3.72 | 3.77 | 1.24 |
| Dec 16 | 3.74 | 3.73 | 3.75 | 0.54 |
| Dec 17 | 3.76 | 3.74 | 3.77 | 0.79 |
| Dec 18 | 3.77 | 3.76 | 3.79 | 0.60 |
| Dec 19 | 3.78 | 3.78 | 3.81 | 1.01 |
| Dec 20 | 3.78 | 3.76 | 3.79 | 0.88 |
| Dec 21 | 3.81 | 3.79 | 3.84 | 1.15 |
| Dec 22 | 3.82 | 3.79 | 3.83 | 0.97 |
| Dec 23 | 3.81 | 3.79 | 3.83 | 1.12 |
| Dec 24 | 3.80 | 3.79 | 3.83 | 1.03 |
| Dec 25 | 3.82 | 3.80 | 3.84 | 1.05 |
| Dec 26 | 3.82 | 3.81 | 3.83 | 0.73 |
| Dec 27 | 3.84 | 3.83 | 3.85 | 0.53 |
| Dec 28 | 3.81 | 3.78 | 3.82 | 1.04 |
| Dec 29 | 3.79 | 3.78 | 3.81 | 0.89 |
| Dec 30 | 3.79 | 3.78 | 3.81 | 0.93 |
| Dec 31 | 3.78 | 3.77 | 3.80 | 0.88 |
| Jan 01 | 3.79 | 3.77 | 3.81 | 1.01 |
| Jan 02 | 3.82 | 3.80 | 3.82 | 0.70 |
| Jan 03 | 3.81 | 3.78 | 3.81 | 0.96 |
| Jan 04 | 3.77 | 3.76 | 3.79 | 0.91 |
| Jan 05 | 3.77 | 3.75 | 3.79 | 1.08 |
| Jan 06 | 3.75 | 3.74 | 3.78 | 1.06 |
| Jan 07 | 3.71 | 3.70 | 3.73 | 0.94 |
Arbutus Biopharma Daily Price Targets
Arbutus Biopharma Stock Forecast 12-09-2024.
Forecast target price for 12-09-2024: $3.70.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.273%.
Pessimistic target level: 3.67
Optimistic target level: 3.72
Arbutus Biopharma Stock Forecast 12-10-2024.
Forecast target price for 12-10-2024: $3.72.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.052%.
Pessimistic target level: 3.70
Optimistic target level: 3.74
Arbutus Biopharma Stock Forecast 12-11-2024.
Forecast target price for 12-11-2024: $3.73.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.499%.
Pessimistic target level: 3.70
Optimistic target level: 3.76
Arbutus Biopharma Stock Forecast 12-12-2024.
Forecast target price for 12-12-2024: $3.73.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 0.938%.
Pessimistic target level: 3.70
Optimistic target level: 3.73
Arbutus Biopharma Stock Forecast 12-13-2024.
Forecast target price for 12-13-2024: $3.73.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.153%.
Pessimistic target level: 3.71
Optimistic target level: 3.75
Arbutus Biopharma Stock Forecast 12-14-2024.
Forecast target price for 12-14-2024: $3.75.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 1.250%.
Pessimistic target level: 3.73
Optimistic target level: 3.78
ABUS (ABUS) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 3.37 | 3.14 | 3.61 | 13.13 |
| Feb. | 3.28 | 3.19 | 3.38 | 5.66 |
| Mar. | 3.42 | 3.33 | 3.50 | 4.94 |
| Apr. | 3.15 | 3.07 | 3.35 | 8.38 |
| May. | 3.29 | 3.02 | 3.57 | 15.33 |
| Jun. | 3.55 | 3.41 | 3.77 | 9.72 |
| Jul. | 3.60 | 3.45 | 3.91 | 11.75 |
| Aug. | 3.45 | 3.24 | 3.59 | 9.71 |
| Sep. | 3.30 | 3.02 | 3.39 | 10.82 |
| Oct. | 3.48 | 3.18 | 3.67 | 13.36 |
| Nov. | 3.62 | 3.38 | 3.70 | 8.71 |
| Dec. | 3.26 | 3.10 | 3.39 | 8.46 |
Arbutus Biopharma forecast for this year
Arbutus Biopharma Stock Prediction for Jan 2025
An downtrend is forecast for this month with an optimal target price of $3.36874. Pessimistic: $3.14. Optimistic: $3.61
Arbutus Biopharma Stock Prediction for Feb 2025
An downtrend is forecast for this month with an optimal target price of $3.28351. Pessimistic: $3.19. Optimistic: $3.38
Arbutus Biopharma Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $3.41715. Pessimistic: $3.33. Optimistic: $3.50
Arbutus Biopharma Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $3.15027. Pessimistic: $3.07. Optimistic: $3.35
Arbutus Biopharma Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $3.29235. Pessimistic: $3.02. Optimistic: $3.57
Arbutus Biopharma Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $3.54586. Pessimistic: $3.41. Optimistic: $3.77
Arbutus Biopharma Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $3.59656. Pessimistic: $3.45. Optimistic: $3.91
Arbutus Biopharma Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $3.44623. Pessimistic: $3.24. Optimistic: $3.59
Arbutus Biopharma Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $3.30217. Pessimistic: $3.02. Optimistic: $3.39
Arbutus Biopharma Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $3.48016. Pessimistic: $3.18. Optimistic: $3.67
Arbutus Biopharma Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $3.61798. Pessimistic: $3.38. Optimistic: $3.70
Arbutus Biopharma Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $3.2598. Pessimistic: $3.10. Optimistic: $3.39
Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.48 | 3.29 | 3.76 | 12.54 |
| Feb | 3.60 | 3.32 | 3.78 | 12.08 |
| Mar | 3.77 | 3.44 | 3.95 | 12.89 |
| Apr | 4.05 | 3.73 | 4.24 | 12.18 |
| May | 4.02 | 3.88 | 4.21 | 7.97 |
| Jun | 4.19 | 3.94 | 4.31 | 8.57 |
| Jul | 4.60 | 4.24 | 4.77 | 11.13 |
| Aug | 4.83 | 4.51 | 5.12 | 11.84 |
| Sep | 4.46 | 4.23 | 4.85 | 12.85 |
| Oct | 4.52 | 4.21 | 4.73 | 10.92 |
| Nov | 4.11 | 3.98 | 4.23 | 5.77 |
| Dec | 4.52 | 4.38 | 4.87 | 10.09 |
Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.32 | 4.18 | 4.46 | 6.29 |
| Feb | 4.28 | 3.95 | 4.38 | 9.69 |
| Mar | 4.68 | 4.33 | 4.83 | 10.24 |
| Apr | 4.61 | 4.28 | 4.86 | 11.89 |
| May | 4.68 | 4.38 | 4.97 | 11.80 |
| Jun | 4.86 | 4.60 | 5.13 | 10.43 |
| Jul | 4.81 | 4.42 | 4.97 | 11.09 |
| Aug | 4.76 | 4.37 | 4.98 | 12.20 |
| Sep | 4.91 | 4.55 | 5.19 | 12.28 |
| Oct | 5.24 | 5.06 | 5.69 | 11.04 |
| Nov | 5.70 | 5.21 | 5.97 | 12.62 |
| Dec | 6.12 | 5.63 | 6.60 | 14.59 |
Arbutus Biopharma information and performance
100-8900 GLENLYON PARKWAY, BURNABY, BC, CA
Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.
EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
